BioCentury
ARTICLE | Clinical News

Tretinoin intravenous all-trans retinoic acid: GENZ began a Phase II/III trial

December 12, 1994 8:00 AM UTC

Genzyme Corp. (GENZ), Cambridge, Mass. Argus Pharmaceuticals Inc. (ARGS), The Woodlands, Texas Product: Tretinoin intravenous all-trans retinoic acid (ATRA) in liposomes Indication: Kaposi's sarcoma ...